Corcept Therapeutics (CORT) Tax Rate (2017 - 2026)
Corcept Therapeutics (CORT) posted Tax Rate of 6.41% for Q2 2026, down 77.95% sequentially from 29.07% in Q1 2026, and up 1745.0% YoY from 0.35% in Q2 2025.
Corcept Therapeutics (CORT) Tax Rate (2017 - 2026) Analysis & Trends
Corcept Therapeutics has reported Tax Rate for 10 years, with the latest figure at 6.41% in Q2 2026.
- Quarterly Tax Rate rose 1745.0% year-over-year to 6.41% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 109.44% (down 10349.0% YoY) and the FY2025 annual result came in at 49.94%, down 6250.0% from the prior year.
- Tax Rate declined to 6.41% in Q2 2026 per CORT's latest filing, from 29.07% in the prior quarter.
- Over five years, Tax Rate peaked at 31.61% in Q4 2022 and troughed at 145.09% in Q4 2025.
- A 5-year average of 5.43% and a median of 13.93% in 2023 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2025 and 2026: Tax Rate sank 14879 bps in 2025, then surged 14270 bps in 2026.
- Over 5 years, Tax Rate stood at 31.61% in 2022, then tumbled by 53 bps to 14.72% in 2023, then tumbled by 75 bps to 3.7% in 2024, then sank by 4016 bps to 145.09% in 2025, then jumped by 104 bps to 6.41% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 6.41%, 29.07%, and 145.09% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 6.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.41% |
| Jun 30, 2026 | 6.41% |
| Jun 30, 2026 | 6.41% |
| Mar 31, 2026 | 29.07% |
| Mar 31, 2026 | 29.07% |
| Mar 31, 2026 | 29.07% |
| Dec 31, 2025 | -145.09% |
| Dec 31, 2025 | -145.09% |
| Dec 31, 2025 | -145.09% |
| Sep 30, 2025 | -29.03% |
| Sep 30, 2025 | -29.03% |
| Sep 30, 2025 | -29.03% |
| Jun 30, 2025 | -11.04% |
| Jun 30, 2025 | -11.04% |
| Jun 30, 2025 | -11.04% |
| Mar 31, 2025 | -113.63% |
| Mar 31, 2025 | -113.63% |
| Mar 31, 2025 | -113.63% |
| Dec 31, 2024 | 3.70% |
| Dec 31, 2024 | 3.70% |